In vitro immunomodulating activity of biosurfactant glycolipid complex from Rhodococcus ruber

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 3, 2007, Pages 326-330

  Kuyukina, M S ^a,b   Ivshina, I B ^a,b   Gein, S V ^a,b   Baeva, T A ^a,b   Chereshnev, V A ^a,b  

^a INSTITUTE OF ECOLOGY AND GENETICS OF MICROORGANISMS   (Russian Federation)

^b PERM STATE UNIVERSITY   (Russian Federation)

Author keywords

Actinobacteria; Biosurfactant; Cytokines; Rhodococcus ruber; Toxicity

Indexed keywords

BIOSURFACTANT; GLYCOLIPID; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL FRACTIONATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKOCYTE FUNCTION; MALE; MONOCYTE; MOUSE; NONHUMAN; RHODOCOCCUS; RHODOCOCCUS RUBER; SINGLE DRUG DOSE;

GLYCOLIPIDS; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES; MONOCYTES; RHODOCOCCUS; SURFACE-ACTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

ACTINOBACTERIA; RHODOCOCCUS RUBER;

EID: 37749012920     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0324-3     Document Type: Article

References (14)

1. M. S. Kuyukina, T. A. Yushkova, I. B. Ivshina, and V. V. Yushkov, Microbiology and Biotechnology of the 21st Century [in Russian], Minsk (2002), pp. 47-48.
2. G. I. Novik, N. I. Astapovich, M. Pastsyak, and A. Gam'yan, Mikrobiologiya, 74, No. 6, 781-787 (2005).
3. W. L. Goff, W. C. Johnson, S. M. Parish, et al., Vet. Immunol. Immunopathol., 84, No. 3-4, 237-251 (2002).
4. I. B. Ivshina, M. S. Kuyukina, J. C. Philp, and N. Christofi, World J. Microbiol. Biotechnol., 14, 711-717 (1998).
5. D. Kitamoto, H. Isoda, and T. Nakahara, J. Biosci. Bioenerg., 94, No. 3, 187-201 (2002).
6. M. S. Kuyukina, I. B. Ivshina, J. C. Philp, et al., J. Microbiol. Methods, 46, No. 2, 149-156 (2001).
7. M. K. Levings and J. W. Schrader, J. Immunol., 162, No. 9, 5224-5229 (1999).
8. R. M. Maier and G. Soberon-Chavez, Appl. Microbiol. Biotechnol., 54, No. 5, 625-633 (2000).
9. A. Nuntapraset, Y. Mori, Y. Muneta, et al., Comp. Immunol. Microbiol. Infect. Dis., 28, No. 2, 83-101 (2005).
10. R. L. Perez, J. Roman, S. Roser, et al., J. Interferon Cytokine Res., 20, No. 9, 795-804 (2000).
11. J. C. Philp, M. S. Kuyukina, I. B. Ivshina, et al., Appl. Microbiol. Biotechnol., 59, No. 2-3, 318-324 (2002).
12. R. Ryll, Y. Kumazawa, and I. Yano, Microbiol. Immunol., 45, No. 12, 801-811 (2001).
13. I. Sakaguchi, N. Ikeda, M. Nakayama, et al., Infect. Immunity, 68, No. 4, 2043-2052 (2000).
14. S. Tsuji, M. Matsumoto, O. Takeuchi, et al., Ibid., No. 12, 6883-6890.